

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 5.19106232 |
| 2 | mitotic metaphase plate congression (GO:0007080) | 4.88061668 |
| 3 | DNA deamination (GO:0045006) | 4.38800570 |
| 4 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.32312635 |
| 5 | protein localization to kinetochore (GO:0034501) | 4.27021141 |
| 6 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 4.25539438 |
| 7 | DNA replication checkpoint (GO:0000076) | 4.22183387 |
| 8 | DNA replication initiation (GO:0006270) | 4.21879536 |
| 9 | maturation of SSU-rRNA (GO:0030490) | 4.20892239 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 4.19254259 |
| 11 | DNA unwinding involved in DNA replication (GO:0006268) | 4.14327519 |
| 12 | metaphase plate congression (GO:0051310) | 4.06670562 |
| 13 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.03625742 |
| 14 | nucleobase biosynthetic process (GO:0046112) | 3.95815641 |
| 15 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.95362019 |
| 16 | protein localization to chromosome, centromeric region (GO:0071459) | 3.94363598 |
| 17 | mitotic chromosome condensation (GO:0007076) | 3.92433050 |
| 18 | purine nucleobase biosynthetic process (GO:0009113) | 3.87625473 |
| 19 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.82000883 |
| 20 | ribosomal small subunit assembly (GO:0000028) | 3.81489812 |
| 21 | regulation of spindle organization (GO:0090224) | 3.79913781 |
| 22 | DNA strand elongation (GO:0022616) | 3.77374030 |
| 23 | mitotic nuclear envelope disassembly (GO:0007077) | 3.76057172 |
| 24 | ribosome biogenesis (GO:0042254) | 3.70360664 |
| 25 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.65265387 |
| 26 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.65265387 |
| 27 | establishment of chromosome localization (GO:0051303) | 3.64045074 |
| 28 | protein complex localization (GO:0031503) | 3.63414072 |
| 29 | ribosome assembly (GO:0042255) | 3.62530634 |
| 30 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.58200649 |
| 31 | folic acid metabolic process (GO:0046655) | 3.56062703 |
| 32 | mitotic sister chromatid segregation (GO:0000070) | 3.54466734 |
| 33 | CENP-A containing nucleosome assembly (GO:0034080) | 3.52825343 |
| 34 | nuclear envelope disassembly (GO:0051081) | 3.52282746 |
| 35 | membrane disassembly (GO:0030397) | 3.52282746 |
| 36 | translational termination (GO:0006415) | 3.51045882 |
| 37 | viral transcription (GO:0019083) | 3.50036340 |
| 38 | chromatin remodeling at centromere (GO:0031055) | 3.49986496 |
| 39 | DNA replication-independent nucleosome organization (GO:0034724) | 3.46883729 |
| 40 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.46883729 |
| 41 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.45250609 |
| 42 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.43086552 |
| 43 | translational initiation (GO:0006413) | 3.42484569 |
| 44 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.41232811 |
| 45 | protein K6-linked ubiquitination (GO:0085020) | 3.39413332 |
| 46 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.37015323 |
| 47 | translational elongation (GO:0006414) | 3.36923237 |
| 48 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.33574386 |
| 49 | regulation of chromosome segregation (GO:0051983) | 3.33527096 |
| 50 | spliceosomal snRNP assembly (GO:0000387) | 3.30812970 |
| 51 | protein localization to chromosome (GO:0034502) | 3.27867799 |
| 52 | negative regulation of chromosome segregation (GO:0051985) | 3.27028003 |
| 53 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.24492750 |
| 54 | spindle checkpoint (GO:0031577) | 3.22985864 |
| 55 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.22971273 |
| 56 | negative regulation of sister chromatid segregation (GO:0033046) | 3.22971273 |
| 57 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.22971273 |
| 58 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.22971273 |
| 59 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.22914607 |
| 60 | mitochondrial DNA metabolic process (GO:0032042) | 3.21478387 |
| 61 | maturation of 5.8S rRNA (GO:0000460) | 3.20516395 |
| 62 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.20322935 |
| 63 | negative regulation of cell killing (GO:0031342) | 3.20322935 |
| 64 | mitotic spindle assembly checkpoint (GO:0007094) | 3.20012540 |
| 65 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.18697245 |
| 66 | ribosomal small subunit biogenesis (GO:0042274) | 3.16189204 |
| 67 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.15256883 |
| 68 | ribosomal large subunit biogenesis (GO:0042273) | 3.15164481 |
| 69 | pentose-phosphate shunt (GO:0006098) | 3.14780368 |
| 70 | spindle assembly checkpoint (GO:0071173) | 3.14292926 |
| 71 | chromatin assembly or disassembly (GO:0006333) | 3.13773487 |
| 72 | rRNA processing (GO:0006364) | 3.10649960 |
| 73 | regulation of exit from mitosis (GO:0007096) | 3.10587959 |
| 74 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.10414144 |
| 75 | regulation of chromatin binding (GO:0035561) | 3.08549100 |
| 76 | histone H2A monoubiquitination (GO:0035518) | 3.08159503 |
| 77 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.06636509 |
| 78 | sister chromatid segregation (GO:0000819) | 3.06332424 |
| 79 | mitotic spindle checkpoint (GO:0071174) | 3.05907895 |
| 80 | rRNA modification (GO:0000154) | 3.05110611 |
| 81 | histone exchange (GO:0043486) | 3.04646180 |
| 82 | rRNA metabolic process (GO:0016072) | 3.03819661 |
| 83 | proline biosynthetic process (GO:0006561) | 3.03250444 |
| 84 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.00034919 |
| 85 | iron-sulfur cluster assembly (GO:0016226) | 2.99796743 |
| 86 | metallo-sulfur cluster assembly (GO:0031163) | 2.99796743 |
| 87 | regulation of mitotic spindle organization (GO:0060236) | 2.99759034 |
| 88 | positive regulation of chromosome segregation (GO:0051984) | 2.98794323 |
| 89 | nuclear envelope organization (GO:0006998) | 2.97161496 |
| 90 | telomere maintenance via recombination (GO:0000722) | 2.97129364 |
| 91 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.96934660 |
| 92 | histone arginine methylation (GO:0034969) | 2.95708427 |
| 93 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.95684673 |
| 94 | regulation of sister chromatid cohesion (GO:0007063) | 2.94060235 |
| 95 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.93480687 |
| 96 | regulation of gene silencing by miRNA (GO:0060964) | 2.93480687 |
| 97 | regulation of gene silencing by RNA (GO:0060966) | 2.93480687 |
| 98 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.93148241 |
| 99 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.93148241 |
| 100 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.92217870 |
| 101 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.88010112 |
| 102 | IMP biosynthetic process (GO:0006188) | 2.87346832 |
| 103 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.86326953 |
| 104 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.86152269 |
| 105 | pinocytosis (GO:0006907) | 2.86119518 |
| 106 | protein targeting to ER (GO:0045047) | 2.86102644 |
| 107 | cotranslational protein targeting to membrane (GO:0006613) | 2.85473739 |
| 108 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.85238673 |
| 109 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.83857121 |
| 110 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.83695355 |
| 111 | negative regulation of histone methylation (GO:0031061) | 2.83194205 |
| 112 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.82855557 |
| 113 | hyperosmotic salinity response (GO:0042538) | 2.82680477 |
| 114 | pseudouridine synthesis (GO:0001522) | 2.82554550 |
| 115 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.81736828 |
| 116 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.81696097 |
| 117 | ATP-dependent chromatin remodeling (GO:0043044) | 2.80782189 |
| 118 | NADPH regeneration (GO:0006740) | 2.80455011 |
| 119 | protein K11-linked ubiquitination (GO:0070979) | 2.79915132 |
| 120 | IMP metabolic process (GO:0046040) | 2.78168667 |
| 121 | telomere maintenance via telomere lengthening (GO:0010833) | 2.77913767 |
| 122 | cellular protein complex disassembly (GO:0043624) | 2.77633275 |
| 123 | mitotic recombination (GO:0006312) | 2.77460048 |
| 124 | negative regulation of necrotic cell death (GO:0060547) | 2.72142194 |
| 125 | negative regulation of mRNA processing (GO:0050686) | 2.71867034 |
| 126 | protein maturation by protein folding (GO:0022417) | 2.68084390 |
| 127 | viral life cycle (GO:0019058) | 2.68052102 |
| 128 | mitochondrial DNA replication (GO:0006264) | 2.63822060 |
| 129 | rRNA transcription (GO:0009303) | 2.62052682 |
| 130 | negative regulation of mRNA metabolic process (GO:1903312) | 2.61743971 |
| 131 | negative regulation of necroptotic process (GO:0060546) | 2.61106271 |
| 132 | mitochondrial calcium ion transport (GO:0006851) | 2.60097955 |
| 133 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.58596554 |
| 134 | Peyers patch development (GO:0048541) | 2.58596554 |
| 135 | regulation of mitochondrial translation (GO:0070129) | 2.56547184 |
| 136 | negative regulation of RNA splicing (GO:0033119) | 2.56486132 |
| 137 | modulation by virus of host process (GO:0019054) | 2.53973315 |
| 138 | peptidyl-arginine methylation (GO:0018216) | 2.52207546 |
| 139 | peptidyl-arginine N-methylation (GO:0035246) | 2.52207546 |
| 140 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.49215249 |
| 141 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.49146641 |
| 142 | transcription from mitochondrial promoter (GO:0006390) | 2.48520201 |
| 143 | cellular protein complex localization (GO:0034629) | 2.46552250 |
| 144 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.46223376 |
| 145 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.45489357 |
| 146 | nucleotide salvage (GO:0043173) | 2.44357894 |
| 147 | protein complex disassembly (GO:0043241) | 2.41094196 |
| 148 | DNA synthesis involved in DNA repair (GO:0000731) | 2.40232983 |
| 149 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.39175843 |
| 150 | mitochondrial fusion (GO:0008053) | 2.36916686 |
| 151 | glucose catabolic process (GO:0006007) | 2.36064859 |
| 152 | cellular response to interleukin-4 (GO:0071353) | 2.34381170 |
| 153 | chromatin assembly (GO:0031497) | 2.31556751 |
| 154 | pyrimidine-containing compound salvage (GO:0008655) | 2.31291427 |
| 155 | pyrimidine nucleoside salvage (GO:0043097) | 2.31291427 |
| 156 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.29352743 |
| 157 | RNA stabilization (GO:0043489) | 2.28446252 |
| 158 | mRNA stabilization (GO:0048255) | 2.28446252 |
| 159 | neutrophil activation involved in immune response (GO:0002283) | 2.28263366 |
| 160 | viral mRNA export from host cell nucleus (GO:0046784) | 2.28253291 |
| 161 | UV protection (GO:0009650) | 2.27269386 |
| 162 | protein localization to endoplasmic reticulum (GO:0070972) | 2.24904896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.77304438 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.31555557 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.96000907 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.81381826 |
| 5 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.09470474 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.88287524 |
| 7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.76985761 |
| 8 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.70200656 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.69289141 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.67128308 |
| 11 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.60153899 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.60011256 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58568208 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.45165025 |
| 15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.43857750 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.41608142 |
| 17 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22292900 |
| 18 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.19149244 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.18661535 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.18231375 |
| 21 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.06505667 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.00962304 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.95655410 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.94628233 |
| 25 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.89403059 |
| 26 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.85418555 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.85409353 |
| 28 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.80320551 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78886099 |
| 30 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.77653094 |
| 31 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.74664008 |
| 32 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.72729387 |
| 33 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71943983 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.70250145 |
| 35 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66765679 |
| 36 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.61250058 |
| 37 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.60963886 |
| 38 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.59922735 |
| 39 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.59083372 |
| 40 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57816050 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56513863 |
| 42 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.56404465 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55940033 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55804695 |
| 45 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.55638759 |
| 46 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.55083905 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51856671 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.51441581 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50928646 |
| 50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46070227 |
| 51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45917008 |
| 52 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.44536580 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.43286694 |
| 54 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42921503 |
| 55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.42881686 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41131048 |
| 57 | MAF_26560356_Chip-Seq_TH2_Human | 1.40450889 |
| 58 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.40247165 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38611883 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38608400 |
| 61 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38235211 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36242211 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35542094 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35483376 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34578416 |
| 66 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.33436609 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33066756 |
| 68 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.32392688 |
| 69 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31483672 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30251307 |
| 71 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.30237597 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29339468 |
| 73 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29311622 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.28832776 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27727695 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27673031 |
| 77 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.26684334 |
| 78 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25843583 |
| 79 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24924045 |
| 80 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23668973 |
| 81 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23335163 |
| 82 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.23294706 |
| 83 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23255914 |
| 84 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.22933863 |
| 85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21532290 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21311385 |
| 87 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20702034 |
| 88 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.19024808 |
| 89 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18290694 |
| 90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18146555 |
| 91 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17907846 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16396259 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15324310 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14766682 |
| 95 | * TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14426946 |
| 96 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13666210 |
| 97 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.13482445 |
| 98 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13008823 |
| 99 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12925641 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12649672 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12267783 |
| 102 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11519590 |
| 103 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.10707260 |
| 104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10219089 |
| 105 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10171525 |
| 106 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.09598933 |
| 107 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09551938 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07288109 |
| 109 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06373807 |
| 110 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.05237772 |
| 111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.04004504 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03783620 |
| 113 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.03601917 |
| 114 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02818161 |
| 115 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.01417507 |
| 116 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98584822 |
| 117 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.97379927 |
| 118 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.97249543 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96496911 |
| 120 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95238272 |
| 121 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.94766263 |
| 122 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.93205668 |
| 123 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.90982919 |
| 124 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90497519 |
| 125 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.90233594 |
| 126 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89483914 |
| 127 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88575824 |
| 128 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.88136921 |
| 129 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86706382 |
| 130 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86389460 |
| 131 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.85167743 |
| 132 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82977051 |
| 133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.82173384 |
| 134 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81297302 |
| 135 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81192079 |
| 136 | P68_20966046_ChIP-Seq_HELA_Human | 0.80859339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.23797395 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.62460118 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.40128735 |
| 4 | MP0003077_abnormal_cell_cycle | 4.00859661 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.88416486 |
| 6 | MP0003123_paternal_imprinting | 3.50573748 |
| 7 | MP0005464_abnormal_platelet_physiology | 3.11373818 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.90703255 |
| 9 | MP0001730_embryonic_growth_arrest | 2.79516131 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.50121412 |
| 11 | MP0008058_abnormal_DNA_repair | 2.42021719 |
| 12 | * MP0008932_abnormal_embryonic_tissue | 2.21372812 |
| 13 | MP0000350_abnormal_cell_proliferation | 2.20039518 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.12858978 |
| 15 | MP0008057_abnormal_DNA_replication | 2.06967001 |
| 16 | MP0001697_abnormal_embryo_size | 2.00976730 |
| 17 | MP0003718_maternal_effect | 1.94480809 |
| 18 | MP0001672_abnormal_embryogenesis/_devel | 1.94454644 |
| 19 | MP0005380_embryogenesis_phenotype | 1.94454644 |
| 20 | MP0002653_abnormal_ependyma_morphology | 1.91812437 |
| 21 | MP0003436_decreased_susceptibility_to | 1.89670167 |
| 22 | MP0003303_peritoneal_inflammation | 1.83845969 |
| 23 | MP0003567_abnormal_fetal_cardiomyocyte | 1.81919049 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.79669196 |
| 25 | MP0002085_abnormal_embryonic_tissue | 1.79068267 |
| 26 | * MP0002080_prenatal_lethality | 1.78909670 |
| 27 | MP0003984_embryonic_growth_retardation | 1.75868502 |
| 28 | MP0002088_abnormal_embryonic_growth/wei | 1.72014411 |
| 29 | MP0009379_abnormal_foot_pigmentation | 1.69218354 |
| 30 | MP0010307_abnormal_tumor_latency | 1.67370584 |
| 31 | MP0002084_abnormal_developmental_patter | 1.67052256 |
| 32 | MP0003646_muscle_fatigue | 1.64909544 |
| 33 | MP0000490_abnormal_crypts_of | 1.63335581 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.59839216 |
| 35 | MP0009840_abnormal_foam_cell | 1.56484020 |
| 36 | MP0002086_abnormal_extraembryonic_tissu | 1.55082155 |
| 37 | MP0002429_abnormal_blood_cell | 1.54411418 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.53461615 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.52078411 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.49277219 |
| 41 | MP0000716_abnormal_immune_system | 1.48522498 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.47785746 |
| 43 | MP0001819_abnormal_immune_cell | 1.45176288 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.43457898 |
| 45 | MP0000313_abnormal_cell_death | 1.42709657 |
| 46 | MP0003121_genomic_imprinting | 1.40639838 |
| 47 | MP0005501_abnormal_skin_physiology | 1.40364733 |
| 48 | MP0003119_abnormal_digestive_system | 1.36130143 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.34121176 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.32942488 |
| 51 | MP0002019_abnormal_tumor_incidence | 1.30993844 |
| 52 | MP0003786_premature_aging | 1.30155452 |
| 53 | MP0000358_abnormal_cell_content/ | 1.29162919 |
| 54 | MP0008004_abnormal_stomach_pH | 1.28560024 |
| 55 | MP0001800_abnormal_humoral_immune | 1.28346157 |
| 56 | MP0001849_ear_inflammation | 1.27512447 |
| 57 | MP0002723_abnormal_immune_serum | 1.24197652 |
| 58 | MP0004197_abnormal_fetal_growth/weight/ | 1.24165831 |
| 59 | MP0002210_abnormal_sex_determination | 1.23878804 |
| 60 | MP0002452_abnormal_antigen_presenting | 1.22744777 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.22367627 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.22064984 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.22049695 |
| 64 | MP0005451_abnormal_body_composition | 1.21057327 |
| 65 | MP0009672_abnormal_birth_weight | 1.18991938 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.15905470 |
| 67 | MP0003315_abnormal_perineum_morphology | 1.13573099 |
| 68 | MP0006054_spinal_hemorrhage | 1.13484042 |
| 69 | MP0005671_abnormal_response_to | 1.13383159 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.12894504 |
| 71 | MP0001145_abnormal_male_reproductive | 1.12514155 |
| 72 | MP0002796_impaired_skin_barrier | 1.12302837 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.12285688 |
| 74 | MP0004808_abnormal_hematopoietic_stem | 1.12202812 |
| 75 | MP0005025_abnormal_response_to | 1.11760672 |
| 76 | MP0006292_abnormal_olfactory_placode | 1.10366567 |
| 77 | MP0000653_abnormal_sex_gland | 1.08143261 |
| 78 | MP0004381_abnormal_hair_follicle | 1.06967785 |
| 79 | MP0004947_skin_inflammation | 1.06686824 |
| 80 | MP0000685_abnormal_immune_system | 1.03776677 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 1.03389679 |
| 82 | MP0001929_abnormal_gametogenesis | 1.03328380 |
| 83 | MP0001119_abnormal_female_reproductive | 1.02296551 |
| 84 | MP0000537_abnormal_urethra_morphology | 1.02164019 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.02127593 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 1.02098832 |
| 87 | MP0005397_hematopoietic_system_phenotyp | 1.01393826 |
| 88 | MP0001545_abnormal_hematopoietic_system | 1.01393826 |
| 89 | MP0000747_muscle_weakness | 0.99771697 |
| 90 | MP0002419_abnormal_innate_immunity | 0.99140559 |
| 91 | MP0002132_abnormal_respiratory_system | 0.97457421 |
| 92 | MP0003866_abnormal_defecation | 0.96159850 |
| 93 | MP0001853_heart_inflammation | 0.96083343 |
| 94 | MP0001851_eye_inflammation | 0.95769642 |
| 95 | MP0004264_abnormal_extraembryonic_tissu | 0.93859466 |
| 96 | MP0003699_abnormal_female_reproductive | 0.91471383 |
| 97 | * MP0005384_cellular_phenotype | 0.89702290 |
| 98 | MP0003724_increased_susceptibility_to | 0.87726709 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.87326291 |
| 100 | MP0002009_preneoplasia | 0.86927825 |
| 101 | MP0002102_abnormal_ear_morphology | 0.86463801 |
| 102 | MP0003828_pulmonary_edema | 0.86270656 |
| 103 | * MP0005621_abnormal_cell_physiology | 0.85071854 |
| 104 | MP0001790_abnormal_immune_system | 0.85011628 |
| 105 | MP0005387_immune_system_phenotype | 0.85011628 |
| 106 | MP0002405_respiratory_system_inflammati | 0.84967897 |
| 107 | MP0002269_muscular_atrophy | 0.84734811 |
| 108 | MP0002877_abnormal_melanocyte_morpholog | 0.84127419 |
| 109 | MP0003186_abnormal_redox_activity | 0.82174961 |
| 110 | MP0000703_abnormal_thymus_morphology | 0.82003865 |
| 111 | MP0002148_abnormal_hypersensitivity_rea | 0.78872524 |
| 112 | MP0002127_abnormal_cardiovascular_syste | 0.78781556 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.78230905 |
| 114 | MP0001293_anophthalmia | 0.78168542 |
| 115 | MP0003283_abnormal_digestive_organ | 0.76080634 |
| 116 | MP0004233_abnormal_muscle_weight | 0.76056197 |
| 117 | MP0001915_intracranial_hemorrhage | 0.74101441 |
| 118 | MP0000465_gastrointestinal_hemorrhage | 0.73566998 |
| 119 | MP0000477_abnormal_intestine_morphology | 0.72827114 |
| 120 | MP0010630_abnormal_cardiac_muscle | 0.72715832 |
| 121 | MP0008260_abnormal_autophagy | 0.72239582 |
| 122 | MP0000759_abnormal_skeletal_muscle | 0.71136814 |
| 123 | MP0000678_abnormal_parathyroid_gland | 0.70960750 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.70899974 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.69443351 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.69417357 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.68738496 |
| 128 | MP0002722_abnormal_immune_system | 0.67446762 |
| 129 | MP0001944_abnormal_pancreas_morphology | 0.67329632 |
| 130 | MP0009278_abnormal_bone_marrow | 0.67171329 |
| 131 | MP0004084_abnormal_cardiac_muscle | 0.66586580 |
| 132 | MP0000858_altered_metastatic_potential | 0.66383231 |
| 133 | MP0004133_heterotaxia | 0.66331408 |
| 134 | MP0005023_abnormal_wound_healing | 0.65747246 |
| 135 | MP0003937_abnormal_limbs/digits/tail_de | 0.64837936 |
| 136 | MP0005187_abnormal_penis_morphology | 0.64229726 |
| 137 | MP0002160_abnormal_reproductive_system | 0.64161193 |
| 138 | MP0000266_abnormal_heart_morphology | 0.62725637 |
| 139 | MP0002398_abnormal_bone_marrow | 0.62633364 |
| 140 | MP0000689_abnormal_spleen_morphology | 0.62289354 |
| 141 | MP0005266_abnormal_metabolism | 0.61268343 |
| 142 | MP0009053_abnormal_anal_canal | 0.61264588 |
| 143 | MP0002111_abnormal_tail_morphology | 0.59878408 |
| 144 | MP0000598_abnormal_liver_morphology | 0.59840658 |
| 145 | MP0000428_abnormal_craniofacial_morphol | 0.59207909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.30527617 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.12489718 |
| 3 | Microretrognathia (HP:0000308) | 4.04467196 |
| 4 | Prolonged bleeding time (HP:0003010) | 4.01531324 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.90964174 |
| 6 | Breast hypoplasia (HP:0003187) | 3.85000291 |
| 7 | Petechiae (HP:0000967) | 3.83352224 |
| 8 | Colon cancer (HP:0003003) | 3.68894336 |
| 9 | Oral leukoplakia (HP:0002745) | 3.63623609 |
| 10 | Multiple enchondromatosis (HP:0005701) | 3.63601030 |
| 11 | Purpura (HP:0000979) | 3.46173939 |
| 12 | Reticulocytopenia (HP:0001896) | 3.44597605 |
| 13 | Progressive external ophthalmoplegia (HP:0000590) | 3.43600356 |
| 14 | Patellar aplasia (HP:0006443) | 3.42997715 |
| 15 | Carpal bone hypoplasia (HP:0001498) | 3.37053195 |
| 16 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.22420060 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.17833666 |
| 18 | Abnormal platelet volume (HP:0011876) | 3.12046116 |
| 19 | Myopathic facies (HP:0002058) | 3.07577782 |
| 20 | Microvesicular hepatic steatosis (HP:0001414) | 3.04455713 |
| 21 | Medulloblastoma (HP:0002885) | 3.04111970 |
| 22 | Exercise-induced myalgia (HP:0003738) | 2.94780973 |
| 23 | Progressive muscle weakness (HP:0003323) | 2.92989634 |
| 24 | Abnormality of the anterior horn cell (HP:0006802) | 2.92526380 |
| 25 | Degeneration of anterior horn cells (HP:0002398) | 2.92526380 |
| 26 | Selective tooth agenesis (HP:0001592) | 2.89261881 |
| 27 | Aplastic anemia (HP:0001915) | 2.89154090 |
| 28 | Ependymoma (HP:0002888) | 2.84562575 |
| 29 | Increased mean platelet volume (HP:0011877) | 2.83386739 |
| 30 | Neoplasm of the pancreas (HP:0002894) | 2.76813438 |
| 31 | Overlapping toe (HP:0001845) | 2.74378498 |
| 32 | Gastrointestinal inflammation (HP:0004386) | 2.73596782 |
| 33 | Nemaline bodies (HP:0003798) | 2.71952402 |
| 34 | Eczematoid dermatitis (HP:0000976) | 2.68679553 |
| 35 | Cerebral hypomyelination (HP:0006808) | 2.66739272 |
| 36 | Epistaxis (HP:0000421) | 2.65816043 |
| 37 | Rough bone trabeculation (HP:0100670) | 2.63849666 |
| 38 | Facial hemangioma (HP:0000329) | 2.63330779 |
| 39 | Fatigue (HP:0012378) | 2.57147176 |
| 40 | Premature ovarian failure (HP:0008209) | 2.55521473 |
| 41 | Trismus (HP:0000211) | 2.54849844 |
| 42 | Secondary amenorrhea (HP:0000869) | 2.51222052 |
| 43 | Muscle fiber inclusion bodies (HP:0100299) | 2.49470048 |
| 44 | Menorrhagia (HP:0000132) | 2.47946460 |
| 45 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.47374439 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.46593018 |
| 47 | Panhypogammaglobulinemia (HP:0003139) | 2.45570628 |
| 48 | Hypertensive crisis (HP:0100735) | 2.43540865 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.43377136 |
| 50 | Cholecystitis (HP:0001082) | 2.43377136 |
| 51 | Pelvic girdle muscle weakness (HP:0003749) | 2.42838519 |
| 52 | Slender long bone (HP:0003100) | 2.42781702 |
| 53 | Abnormality of alanine metabolism (HP:0010916) | 2.41359383 |
| 54 | Hyperalaninemia (HP:0003348) | 2.41359383 |
| 55 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.41359383 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.41327834 |
| 57 | Increased serum ferritin (HP:0003281) | 2.39936020 |
| 58 | Macrocytic anemia (HP:0001972) | 2.39085913 |
| 59 | Obstructive lung disease (HP:0006536) | 2.38446257 |
| 60 | Chronic obstructive pulmonary disease (HP:0006510) | 2.38446257 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.37307011 |
| 62 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36446882 |
| 63 | Hepatosplenomegaly (HP:0001433) | 2.35330553 |
| 64 | Rhabdomyosarcoma (HP:0002859) | 2.33166386 |
| 65 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.30327893 |
| 66 | Late onset (HP:0003584) | 2.28235129 |
| 67 | Cellulitis (HP:0100658) | 2.26993079 |
| 68 | Recurrent viral infections (HP:0004429) | 2.26377116 |
| 69 | Dysphonia (HP:0001618) | 2.25603478 |
| 70 | Angiofibromas (HP:0010615) | 2.24594882 |
| 71 | Adenoma sebaceum (HP:0009720) | 2.24594882 |
| 72 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.24140536 |
| 73 | Distal lower limb muscle weakness (HP:0009053) | 2.23540558 |
| 74 | Colitis (HP:0002583) | 2.21606468 |
| 75 | Rhabdomyolysis (HP:0003201) | 2.20079355 |
| 76 | Myelodysplasia (HP:0002863) | 2.18974398 |
| 77 | Absent thumb (HP:0009777) | 2.18658021 |
| 78 | Meckel diverticulum (HP:0002245) | 2.17050648 |
| 79 | Muscle stiffness (HP:0003552) | 2.15862579 |
| 80 | Agnosia (HP:0010524) | 2.15160754 |
| 81 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.14139697 |
| 82 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.13773797 |
| 83 | Chromsome breakage (HP:0040012) | 2.12989260 |
| 84 | Abnormal platelet function (HP:0011869) | 2.11531223 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.11531223 |
| 86 | Basal cell carcinoma (HP:0002671) | 2.11152884 |
| 87 | External ophthalmoplegia (HP:0000544) | 2.10362700 |
| 88 | Pallor (HP:0000980) | 2.09226834 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.09186743 |
| 90 | Biliary tract neoplasm (HP:0100574) | 2.09127069 |
| 91 | Abnormality of the preputium (HP:0100587) | 2.09051595 |
| 92 | Stomatitis (HP:0010280) | 2.08369522 |
| 93 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.07118103 |
| 94 | Male infertility (HP:0003251) | 2.06525146 |
| 95 | Global brain atrophy (HP:0002283) | 2.04862209 |
| 96 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.02778384 |
| 97 | Truncus arteriosus (HP:0001660) | 2.02712560 |
| 98 | CNS hypomyelination (HP:0003429) | 2.02504180 |
| 99 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01937021 |
| 100 | Abnormality of the ileum (HP:0001549) | 2.01374419 |
| 101 | Agammaglobulinemia (HP:0004432) | 2.00940280 |
| 102 | Abnormality of chromosome stability (HP:0003220) | 2.00244014 |
| 103 | Abnormality of the umbilical cord (HP:0010881) | 1.99967135 |
| 104 | Seborrheic dermatitis (HP:0001051) | 1.99107714 |
| 105 | Abnormality of lateral ventricle (HP:0030047) | 1.96614555 |
| 106 | Ankle contracture (HP:0006466) | 1.95676024 |
| 107 | Thrombocytosis (HP:0001894) | 1.95632177 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.95568729 |
| 109 | Cortical dysplasia (HP:0002539) | 1.95013900 |
| 110 | Unsteady gait (HP:0002317) | 1.93680106 |
| 111 | Prominent nose (HP:0000448) | 1.93170994 |
| 112 | Amaurosis fugax (HP:0100576) | 1.92868724 |
| 113 | Deep palmar crease (HP:0006191) | 1.92798664 |
| 114 | Paralysis (HP:0003470) | 1.92273999 |
| 115 | Bulbar palsy (HP:0001283) | 1.90850713 |
| 116 | Shawl scrotum (HP:0000049) | 1.90536146 |
| 117 | Atresia of the external auditory canal (HP:0000413) | 1.90378144 |
| 118 | Cafe-au-lait spot (HP:0000957) | 1.89770865 |
| 119 | Broad distal phalanx of finger (HP:0009836) | 1.89066379 |
| 120 | Testicular atrophy (HP:0000029) | 1.88259788 |
| 121 | Short middle phalanx of the 5th finger (HP:0004220) | 1.88182436 |
| 122 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.86783595 |
| 123 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.86783595 |
| 124 | Impaired proprioception (HP:0010831) | 1.86078311 |
| 125 | Neoplasm of the colon (HP:0100273) | 1.85980823 |
| 126 | Generalized amyotrophy (HP:0003700) | 1.85448653 |
| 127 | Gastrointestinal dysmotility (HP:0002579) | 1.85401131 |
| 128 | EMG: myopathic abnormalities (HP:0003458) | 1.83180524 |
| 129 | Septate vagina (HP:0001153) | 1.83011122 |
| 130 | Absent radius (HP:0003974) | 1.82974927 |
| 131 | Abnormal pupillary function (HP:0007686) | 1.82893604 |
| 132 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.82187619 |
| 133 | Small intestinal stenosis (HP:0012848) | 1.80933426 |
| 134 | Duodenal stenosis (HP:0100867) | 1.80933426 |
| 135 | IgM deficiency (HP:0002850) | 1.80904538 |
| 136 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.80823264 |
| 137 | Impulsivity (HP:0100710) | 1.80088911 |
| 138 | Shoulder girdle muscle weakness (HP:0003547) | 1.80003534 |
| 139 | Intestinal polyp (HP:0005266) | 1.79377599 |
| 140 | Distal lower limb amyotrophy (HP:0008944) | 1.79014398 |
| 141 | Areflexia of lower limbs (HP:0002522) | 1.78713761 |
| 142 | Easy fatigability (HP:0003388) | 1.78568705 |
| 143 | Calcaneovalgus deformity (HP:0001848) | 1.78036491 |
| 144 | Increased connective tissue (HP:0009025) | 1.77970627 |
| 145 | Tracheoesophageal fistula (HP:0002575) | 1.77947947 |
| 146 | Abnormal trabecular bone morphology (HP:0100671) | 1.77402949 |
| 147 | Cellular immunodeficiency (HP:0005374) | 1.76565039 |
| 148 | Insulin resistance (HP:0000855) | 1.76311391 |
| 149 | Capillary hemangiomas (HP:0005306) | 1.75612887 |
| 150 | Postnatal microcephaly (HP:0005484) | 1.75357458 |
| 151 | Cleft eyelid (HP:0000625) | 1.74762939 |
| 152 | Increased IgM level (HP:0003496) | 1.74559294 |
| 153 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.74125395 |
| 154 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.74125395 |
| 155 | Intestinal polyposis (HP:0200008) | 1.73973371 |
| 156 | Neoplasm of the rectum (HP:0100743) | 1.73112540 |
| 157 | Abnormal biliary tract morphology (HP:0012440) | 1.73018720 |
| 158 | Recurrent bacterial skin infections (HP:0005406) | 1.72627955 |
| 159 | Bicuspid aortic valve (HP:0001647) | 1.72614374 |
| 160 | Proximal placement of thumb (HP:0009623) | 1.72337079 |
| 161 | Abnormality of reticulocytes (HP:0004312) | 1.72076183 |
| 162 | Neoplasm of striated muscle (HP:0009728) | 1.71581123 |
| 163 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71457686 |
| 164 | Ragged-red muscle fibers (HP:0003200) | 1.71412070 |
| 165 | Death in infancy (HP:0001522) | 1.71033158 |
| 166 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.70037514 |
| 167 | Mediastinal lymphadenopathy (HP:0100721) | 1.70006324 |
| 168 | Bone marrow hypocellularity (HP:0005528) | 1.69882189 |
| 169 | Abnormality of the duodenum (HP:0002246) | 1.68855282 |
| 170 | Personality changes (HP:0000751) | 1.67717356 |
| 171 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.66709817 |
| 172 | Single umbilical artery (HP:0001195) | 1.66709817 |
| 173 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.66709817 |
| 174 | Reduced antithrombin III activity (HP:0001976) | 1.65863229 |
| 175 | Horseshoe kidney (HP:0000085) | 1.65395278 |
| 176 | Abnormality of the calcaneus (HP:0008364) | 1.65311558 |
| 177 | Gingival bleeding (HP:0000225) | 1.65092836 |
| 178 | Deformed tarsal bones (HP:0008119) | 1.65005007 |
| 179 | Myoglobinuria (HP:0002913) | 1.63233605 |
| 180 | Growth hormone excess (HP:0000845) | 1.63212192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.42930139 |
| 2 | NEK2 | 3.44923402 |
| 3 | WEE1 | 3.35735635 |
| 4 | EEF2K | 3.28805564 |
| 5 | SMG1 | 3.25600639 |
| 6 | CDC7 | 3.22575202 |
| 7 | PRPF4B | 3.02049471 |
| 8 | ACVR1B | 2.55100735 |
| 9 | NEK1 | 2.44360014 |
| 10 | DYRK3 | 2.42328502 |
| 11 | TRIB3 | 2.34447744 |
| 12 | TTK | 2.23242576 |
| 13 | EIF2AK1 | 2.19692767 |
| 14 | NME2 | 2.06802889 |
| 15 | PKN2 | 2.04401091 |
| 16 | LATS2 | 2.00404958 |
| 17 | STK16 | 1.94529205 |
| 18 | BRSK2 | 1.94009109 |
| 19 | RPS6KA4 | 1.91535337 |
| 20 | MAPKAPK3 | 1.89068959 |
| 21 | MAP3K10 | 1.84958876 |
| 22 | PLK1 | 1.81786122 |
| 23 | RPS6KB2 | 1.78495277 |
| 24 | PLK4 | 1.71613223 |
| 25 | TAOK2 | 1.70363068 |
| 26 | SCYL2 | 1.67469855 |
| 27 | PBK | 1.65179500 |
| 28 | BRAF | 1.57996304 |
| 29 | KSR2 | 1.55629770 |
| 30 | AURKB | 1.55585580 |
| 31 | VRK2 | 1.55132129 |
| 32 | CDK7 | 1.48573210 |
| 33 | RIPK4 | 1.45262139 |
| 34 | AURKA | 1.42592262 |
| 35 | TESK2 | 1.42300505 |
| 36 | CDK4 | 1.42213501 |
| 37 | ZAK | 1.41953532 |
| 38 | MAP3K8 | 1.41407024 |
| 39 | RAF1 | 1.38949559 |
| 40 | TAOK1 | 1.38867229 |
| 41 | MAP3K13 | 1.37631747 |
| 42 | BCKDK | 1.35606235 |
| 43 | BRSK1 | 1.35433372 |
| 44 | IRAK3 | 1.33781288 |
| 45 | PIM2 | 1.32402980 |
| 46 | PASK | 1.27673140 |
| 47 | CHEK2 | 1.25289304 |
| 48 | FES | 1.21327667 |
| 49 | BMX | 1.19394529 |
| 50 | TTN | 1.16650992 |
| 51 | EIF2AK3 | 1.16295504 |
| 52 | BTK | 1.14317704 |
| 53 | PAK4 | 1.13099476 |
| 54 | STK10 | 1.10052409 |
| 55 | MAP3K1 | 1.09815803 |
| 56 | CDK8 | 1.07082257 |
| 57 | DYRK2 | 1.06011167 |
| 58 | KSR1 | 1.05755347 |
| 59 | CDK12 | 1.03914599 |
| 60 | MAP2K3 | 1.03456726 |
| 61 | MAP3K11 | 1.02981047 |
| 62 | TLK1 | 1.02707578 |
| 63 | SRPK1 | 1.01728520 |
| 64 | TBK1 | 0.98170251 |
| 65 | VRK1 | 0.97769094 |
| 66 | ATR | 0.97080077 |
| 67 | FLT3 | 0.92820899 |
| 68 | IRAK4 | 0.89830375 |
| 69 | ARAF | 0.88966202 |
| 70 | STK38L | 0.88229132 |
| 71 | LATS1 | 0.86228157 |
| 72 | CDK19 | 0.85630697 |
| 73 | PAK1 | 0.84137431 |
| 74 | MAP3K6 | 0.83730658 |
| 75 | SIK1 | 0.82464680 |
| 76 | NME1 | 0.81891056 |
| 77 | KDR | 0.80985108 |
| 78 | CHEK1 | 0.80649645 |
| 79 | MAP3K9 | 0.80374497 |
| 80 | CSF1R | 0.79451482 |
| 81 | IRAK2 | 0.78486518 |
| 82 | PLK3 | 0.76005840 |
| 83 | JAK3 | 0.74703376 |
| 84 | PRKCI | 0.73785302 |
| 85 | STK3 | 0.72307540 |
| 86 | ICK | 0.70366207 |
| 87 | TYK2 | 0.69262859 |
| 88 | ERN1 | 0.68010172 |
| 89 | MELK | 0.65163985 |
| 90 | IKBKB | 0.63359976 |
| 91 | CDK2 | 0.62267531 |
| 92 | ILK | 0.61112628 |
| 93 | EPHA2 | 0.60924015 |
| 94 | LRRK2 | 0.59796322 |
| 95 | TGFBR1 | 0.58840180 |
| 96 | MAPK11 | 0.58647662 |
| 97 | TESK1 | 0.58004921 |
| 98 | HCK | 0.57226553 |
| 99 | ABL2 | 0.54701815 |
| 100 | MAP3K14 | 0.53986387 |
| 101 | CSK | 0.53106600 |
| 102 | MAPK12 | 0.52234888 |
| 103 | STK4 | 0.52013311 |
| 104 | MTOR | 0.50701431 |
| 105 | FGFR4 | 0.49587693 |
| 106 | DAPK1 | 0.49346800 |
| 107 | TSSK6 | 0.48144089 |
| 108 | ZAP70 | 0.46924780 |
| 109 | PRKD2 | 0.46482067 |
| 110 | PIM1 | 0.46136946 |
| 111 | ERBB4 | 0.45012158 |
| 112 | AKT2 | 0.44202657 |
| 113 | ATM | 0.43825940 |
| 114 | MAPKAPK2 | 0.43809176 |
| 115 | RPS6KL1 | 0.42437039 |
| 116 | RPS6KC1 | 0.42437039 |
| 117 | MAP4K1 | 0.42323796 |
| 118 | GRK6 | 0.41901064 |
| 119 | MOS | 0.41595321 |
| 120 | MAP3K5 | 0.40477971 |
| 121 | SYK | 0.38324577 |
| 122 | FGR | 0.37640562 |
| 123 | CDK9 | 0.37292710 |
| 124 | DAPK3 | 0.37020587 |
| 125 | MAP2K2 | 0.36962607 |
| 126 | CDK1 | 0.36911948 |
| 127 | TNK2 | 0.36471486 |
| 128 | HIPK2 | 0.34948715 |
| 129 | RPS6KA5 | 0.32619558 |
| 130 | ALK | 0.31529989 |
| 131 | CSNK2A1 | 0.31251461 |
| 132 | CSNK2A2 | 0.30213442 |
| 133 | RPS6KA1 | 0.29445175 |
| 134 | MAP3K3 | 0.28140018 |
| 135 | CDK6 | 0.28003050 |
| 136 | CCNB1 | 0.25111123 |
| 137 | TYRO3 | 0.23517007 |
| 138 | DYRK1B | 0.23046418 |
| 139 | MKNK1 | 0.22920852 |
| 140 | MARK3 | 0.22419361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.49523347 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.66766749 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.45917453 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.31690018 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.27549642 |
| 6 | Cell cycle_Homo sapiens_hsa04110 | 3.27024129 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 3.25097039 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 3.16207938 |
| 9 | Base excision repair_Homo sapiens_hsa03410 | 2.82452194 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.56576136 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.37824133 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.37033193 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.26942385 |
| 14 | RNA degradation_Homo sapiens_hsa03018 | 2.03134955 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.00648924 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.00190902 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 1.94320568 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.92337722 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.74066414 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.72484759 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.70564820 |
| 22 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.68146675 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.60866594 |
| 24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.60483087 |
| 25 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.49736925 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44755812 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.43101949 |
| 28 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.41988151 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39028743 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.37841938 |
| 31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.27043870 |
| 32 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.23071570 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16680102 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.14894713 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.11632413 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09866087 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07652729 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04583671 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.03699629 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03424504 |
| 41 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.99362365 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.98626823 |
| 43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98232045 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97798703 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97227379 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.96680515 |
| 47 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96284474 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94630027 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93147078 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.92155427 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90030062 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.89882886 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82966037 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81460940 |
| 55 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78826762 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.78282010 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77625299 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76646994 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75780721 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75515331 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75093220 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74179707 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73675451 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72040784 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71027845 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70913767 |
| 67 | Protein export_Homo sapiens_hsa03060 | 0.69301517 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66117772 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65432925 |
| 70 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64833283 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64214202 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.61307790 |
| 73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61034449 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60902532 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.60538708 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59776439 |
| 77 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.59375069 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58927789 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.58264795 |
| 80 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.58203020 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.56954319 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56808186 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56517995 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.54580361 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53367541 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53334313 |
| 87 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51640014 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47456742 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46802670 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.46293030 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46162694 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45624073 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.44940902 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.44642095 |
| 95 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44540255 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44346199 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.44322578 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.41930744 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41379930 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40940043 |
| 101 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40490465 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39845581 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39625460 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38294318 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38006173 |
| 106 | Huntingtons disease_Homo sapiens_hsa05016 | 0.36752163 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.34834817 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34492793 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33130639 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31949803 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31481003 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30674609 |
| 113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.29916239 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.29743803 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29469085 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.28560634 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28451782 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.26571950 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.25799957 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.24633513 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24614975 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23159378 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.22433029 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21842672 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.21426031 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20496862 |
| 127 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.18841661 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18121581 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.17989913 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17492261 |
| 131 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17425155 |

